In the last 12 months, insiders at ZEVRA THERAPEUTICS, INC. ($ZVRA) filed 151 transactions with the SEC: 37 open-market purchases totaling $825,103 and 15 sales totaling $2,575,835. Net insider sentiment: net selling.
ZEVRA THERAPEUTICS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- McFarlane Neil F. (President and CEO) — 20 transactions totaling $1,916,909
- Bode John B (Director) — 17 transactions totaling $672,373
- Clifton R. LaDuane (Other) — 5 transactions totaling $434,676
- Thompson Rahsaan (Chief Legal & Compliance) — 11 transactions totaling $257,014
- Shih Alvin (Director) — 4 transactions totaling $157,800
View all SEC Filings for ZEVRA THERAPEUTICS, INC. (ZVRA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 24, 2026 | Bode John B | Director | M | Stock Option (right to buy) | 39200 | $0.00 | 0.0000 | 56,783,000 | 100.00% | 0.07% |
| March 24, 2026 | Bode John B | Director | M | Stock Option (right to buy) | 39200 | $0.00 | 19,600.0000 | 56,783,000 | 66.67% | 0.07% |
| March 24, 2026 | Bode John B | Director | M | Common Stock | 39200 | $4.89 | 123,400.0000 | 56,783,000 | 46.56% | 0.07% |
| March 24, 2026 | Bode John B | Director | M | Common Stock | 39200 | $4.97 | 84,200.0000 | 56,783,000 | 87.11% | 0.07% |
| March 18, 2026 | Renz Justin A | CFO | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 56,783,000 | 9999.99% | 0.53% |
| Feb. 9, 2026 | McFarlane Neil F. | President and CEO | S | Common Stock | 14625 | $8.56 | 387,225.0000 | 56,783,000 | 3.64% | 0.03% |
| Feb. 7, 2026 | McFarlane Neil F. | President and CEO | M | Common Stock | 37500 | $0.00 | 401,850.0000 | 56,783,000 | 10.29% | 0.07% |
| Feb. 7, 2026 | McFarlane Neil F. | President and CEO | M | Restricted Stock Unit | 37500 | $0.00 | 75,000.0000 | 56,783,000 | 33.33% | 0.07% |
| Feb. 3, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | S | Common Stock | 3000 | $9.18 | 29,590.0000 | 56,783,000 | 9.21% | 0.01% |
| Feb. 3, 2026 | Schafer Joshua | CCO | S | Common Stock | 10500 | $9.19 | 62,278.0000 | 56,783,000 | 14.43% | 0.02% |
| Jan. 30, 2026 | Quartel Adrian W | Chief Medical Officer | M | Restricted Stock Unit | 11333 | $0.00 | 22,667.0000 | 56,783,000 | 33.33% | 0.02% |
| Jan. 30, 2026 | Schafer Joshua | CCO | M | Common Stock | 11333 | $0.00 | 40,819.0000 | 56,783,000 | 38.44% | 0.02% |
| Jan. 30, 2026 | Schafer Joshua | CCO | S | Common Stock | 3375 | $8.83 | 37,444.0000 | 56,783,000 | 8.27% | 0.01% |
| Jan. 31, 2026 | Schafer Joshua | CCO | M | Common Stock | 35334 | $0.00 | 72,778.0000 | 56,783,000 | 94.36% | 0.06% |
| Jan. 29, 2026 | Schafer Joshua | CCO | A | Restricted Stock Unit | 37500 | $0.00 | 37,500.0000 | 56,783,000 | 9999.99% | 0.07% |
| Jan. 29, 2026 | Schafer Joshua | CCO | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 56,783,000 | 9999.99% | 0.13% |
| Jan. 31, 2026 | McFarlane Neil F. | President and CEO | M | Restricted Stock Unit | 233334 | $0.00 | 233,333.0000 | 56,783,000 | 50.00% | 0.41% |
| Jan. 29, 2026 | McFarlane Neil F. | President and CEO | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 56,783,000 | 9999.99% | 0.44% |
| Jan. 29, 2026 | McFarlane Neil F. | President and CEO | A | Restricted Stock Unit | 125000 | $0.00 | 125,000.0000 | 56,783,000 | 9999.99% | 0.22% |
| Feb. 2, 2026 | McFarlane Neil F. | President and CEO | S | Common Stock | 91000 | $9.38 | 364,350.0000 | 56,783,000 | 19.98% | 0.16% |
| Jan. 31, 2026 | McFarlane Neil F. | President and CEO | M | Common Stock | 233334 | $0.00 | 455,350.0000 | 56,783,000 | 105.10% | 0.41% |
| Jan. 31, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | M | Restricted Stock Unit | 11666 | $0.00 | 11,668.0000 | 56,783,000 | 50.00% | 0.02% |
| Jan. 30, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | M | Restricted Stock Unit | 6333 | $0.00 | 12,667.0000 | 56,783,000 | 33.33% | 0.01% |
| Jan. 31, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | M | Common Stock | 11666 | $0.00 | 32,590.0000 | 56,783,000 | 55.75% | 0.02% |
| Jan. 30, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | S | Common Stock | 1750 | $8.82 | 20,924.0000 | 56,783,000 | 7.72% | 0.00% |
| Jan. 30, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | M | Common Stock | 6333 | $0.00 | 22,674.0000 | 56,783,000 | 38.76% | 0.01% |
| Jan. 30, 2026 | Schafer Joshua | CCO | M | Restricted Stock Unit | 11333 | $0.00 | 22,667.0000 | 56,783,000 | 33.33% | 0.02% |
| Jan. 31, 2026 | Schafer Joshua | CCO | M | Restricted Stock Unit | 35334 | $0.00 | 35,333.0000 | 56,783,000 | 50.00% | 0.06% |
| Jan. 30, 2026 | Thompson Rahsaan | Chief Legal & Compliance | M | Common Stock | 11333 | $0.00 | 53,999.0000 | 56,783,000 | 26.56% | 0.02% |
| Jan. 30, 2026 | Thompson Rahsaan | Chief Legal & Compliance | S | Common Stock | 4080 | $8.83 | 49,919.0000 | 56,783,000 | 7.56% | 0.01% |
| Jan. 29, 2026 | Thompson Rahsaan | Chief Legal & Compliance | A | Restricted Stock Unit | 37500 | $0.00 | 37,500.0000 | 56,783,000 | 9999.99% | 0.07% |
| Jan. 29, 2026 | Thompson Rahsaan | Chief Legal & Compliance | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 56,783,000 | 9999.99% | 0.13% |
| Jan. 30, 2026 | Thompson Rahsaan | Chief Legal & Compliance | M | Restricted Stock Unit | 11333 | $0.00 | 22,667.0000 | 56,783,000 | 33.33% | 0.02% |
| Jan. 30, 2026 | Quartel Adrian W | Chief Medical Officer | M | Common Stock | 11333 | $0.00 | 14,256.0000 | 56,783,000 | 387.72% | 0.02% |
| Jan. 30, 2026 | Quartel Adrian W | Chief Medical Officer | S | Common Stock | 4533 | $8.83 | 9,723.0000 | 56,783,000 | 31.80% | 0.01% |
| Jan. 29, 2026 | Quartel Adrian W | Chief Medical Officer | A | Restricted Stock Unit | 37500 | $0.00 | 37,500.0000 | 56,783,000 | 9999.99% | 0.07% |
| Jan. 29, 2026 | Quartel Adrian W | Chief Medical Officer | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 56,783,000 | 9999.99% | 0.13% |
| Dec. 31, 2025 | Clifton R. LaDuane | Other | M | Restricted Stock Unit | 86667 | $0.00 | 0.0000 | 56,783,000 | 100.00% | 0.15% |
| Dec. 31, 2025 | Clifton R. LaDuane | Other | M | Performance Stock Unit | 20000 | $0.00 | 0.0000 | 56,783,000 | 100.00% | 0.04% |
| Dec. 31, 2025 | Clifton R. LaDuane | Other | M | Restricted Stock Unit | 34000 | $0.00 | 0.0000 | 56,783,000 | 100.00% | 0.06% |
| Dec. 31, 2025 | Clifton R. LaDuane | Other | F | Common Stock | 48513 | $8.96 | 143,515.0000 | 56,783,000 | 25.26% | 0.09% |
| Dec. 31, 2025 | Clifton R. LaDuane | Other | M | Common Stock | 140667 | $0.00 | 192,028.0000 | 56,783,000 | 273.88% | 0.25% |
| Dec. 2, 2025 | Secor Alicia | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 56,783,000 | 9999.99% | 0.08% |
| Oct. 10, 2025 | McFarlane Neil F. | President and CEO | M | Common Stock | 50000 | $0.00 | 241,516.0000 | 56,783,000 | 26.11% | 0.09% |
| Oct. 10, 2025 | McFarlane Neil F. | President and CEO | S | Common Stock | 19500 | $10.82 | 222,016.0000 | 56,783,000 | 8.07% | 0.03% |
| Oct. 10, 2025 | McFarlane Neil F. | President and CEO | M | Restricted Stock Unit | 50000 | $0.00 | 100,000.0000 | 56,783,000 | 33.33% | 0.09% |
| Sept. 12, 2025 | FAVORITO TAMARA A | Director | P | Common Stock | 3175 | $7.79 | 3,894.0000 | 47,808,817 | 441.59% | 0.01% |
| Sept. 12, 2025 | Shih Alvin | Director | P | Common Stock | 20000 | $7.89 | 20,000.0000 | 47,808,817 | 9999.99% | 0.04% |
| Aug. 19, 2025 | Bode John B | Director | P | Common Stock | 5000 | $9.17 | 45,000.0000 | 47,808,817 | 12.50% | 0.01% |
| June 26, 2025 | Thompson Rahsaan | Chief Legal & Compliance | S | Common Stock | 24000 | $9.21 | 42,666.0000 | 47,808,817 | 36.00% | 0.05% |
| June 21, 2025 | Thompson Rahsaan | Chief Legal & Compliance | M | Common Stock | 66666 | $0.00 | 66,666.0000 | 47,808,817 | 9999.99% | 0.14% |
| June 21, 2025 | Thompson Rahsaan | Chief Legal & Compliance | M | Restricted Stock Unit | 66666 | $0.00 | 133,334.0000 | 47,808,817 | 33.33% | 0.14% |
| May 29, 2025 | Shih Alvin | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 47,808,817 | 9999.99% | 0.06% |
| May 29, 2025 | Anderson Thomas | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 47,808,817 | 9999.99% | 0.06% |
| May 29, 2025 | Bode John B | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 47,808,817 | 9999.99% | 0.06% |
| May 29, 2025 | Watton Corey Michael | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 47,808,817 | 9999.99% | 0.06% |
| May 29, 2025 | FAVORITO TAMARA A | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 47,808,817 | 9999.99% | 0.06% |
| May 29, 2025 | Calder Douglas W | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 47,808,817 | 9999.99% | 0.06% |
| May 29, 2025 | DIXON WENDY L | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 47,808,817 | 9999.99% | 0.06% |
| March 28, 2025 | Watton Corey Michael | Director | P | Common Stock | 300 | $7.84 | 1,800.0000 | 47,808,817 | 20.00% | 0.00% |
| Jan. 30, 2025 | Quartel Adrian W | Chief Medical Officer | A | Stock Option (right to buy) | 68000 | $0.00 | 68,000.0000 | 47,808,817 | 9999.99% | 0.14% |
| Jan. 30, 2025 | Quartel Adrian W | Chief Medical Officer | A | Restricted Stock Unit | 34000 | $0.00 | 34,000.0000 | 47,808,817 | 9999.99% | 0.07% |
| March 19, 2025 | Bode John B | Director | P | Common Stock | 10000 | $7.96 | 40,000.0000 | 47,808,817 | 33.33% | 0.02% |
| Feb. 13, 2025 | Clifton R. LaDuane | CFO & Treasurer | S | Common Stock | 11000 | $7.86 | 51,361.0000 | 47,808,817 | 17.64% | 0.02% |
| Feb. 13, 2025 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | S | Common Stock | 3000 | $7.86 | 16,341.0000 | 47,808,817 | 15.51% | 0.01% |
| Feb. 13, 2025 | Schafer Joshua | CCO & EVP, Bus. Development | S | Common Stock | 10500 | $7.86 | 29,486.0000 | 47,808,817 | 26.26% | 0.02% |
| Feb. 13, 2025 | McFarlane Neil F. | President and CEO | S | Common Stock | 61273 | $7.86 | 222,060.0000 | 47,808,817 | 21.63% | 0.13% |
| Feb. 14, 2025 | McFarlane Neil F. | President and CEO | S | Common Stock | 30544 | $8.05 | 191,516.0000 | 47,808,817 | 13.75% | 0.06% |
| Feb. 7, 2025 | McFarlane Neil F. | President and CEO | A | Restricted Stock Unit | 112500 | $0.00 | 112,500.0000 | 47,808,817 | 9999.99% | 0.24% |
| Feb. 7, 2025 | McFarlane Neil F. | President and CEO | A | Stock Option (right to buy) | 225000 | $0.00 | 225,000.0000 | 47,808,817 | 9999.99% | 0.47% |
| Jan. 31, 2025 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | M | Restricted Stock Unit | 11666 | $0.00 | 23,334.0000 | 47,808,817 | 33.33% | 0.02% |
| Jan. 30, 2025 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | A | Stock Option (right to buy) | 38000 | $0.00 | 38,000.0000 | 47,808,817 | 9999.99% | 0.08% |
| Jan. 30, 2025 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | A | Restricted Stock Unit | 19000 | $0.00 | 19,000.0000 | 47,808,817 | 9999.99% | 0.04% |
| Jan. 30, 2025 | Thompson Rahsaan | Chief Legal & Compliance | A | Stock Option (right to buy) | 68000 | $0.00 | 68,000.0000 | 47,808,817 | 9999.99% | 0.14% |
| Jan. 30, 2025 | Thompson Rahsaan | Chief Legal & Compliance | A | Restricted Stock Unit | 34000 | $0.00 | 34,000.0000 | 47,808,817 | 9999.99% | 0.07% |
| Jan. 31, 2025 | Schafer Joshua | CCO & EVP, Bus. Development | M | Common Stock | 35333 | $0.00 | 39,986.0000 | 47,808,817 | 759.36% | 0.07% |
| Jan. 31, 2025 | Schafer Joshua | CCO & EVP, Bus. Development | M | Restricted Stock Unit | 35333 | $0.00 | 70,667.0000 | 47,808,817 | 33.33% | 0.07% |
| Jan. 30, 2025 | Schafer Joshua | CCO & EVP, Bus. Development | A | Stock Option (right to buy) | 68000 | $0.00 | 68,000.0000 | 47,808,817 | 9999.99% | 0.14% |
| Jan. 30, 2025 | Schafer Joshua | CCO & EVP, Bus. Development | A | Restricted Stock Unit | 34000 | $0.00 | 34,000.0000 | 47,808,817 | 9999.99% | 0.07% |
| Jan. 31, 2025 | Clifton R. LaDuane | CFO & Treasurer | M | Common Stock | 43333 | $0.00 | 62,361.0000 | 47,808,817 | 227.73% | 0.09% |
| Jan. 31, 2025 | Clifton R. LaDuane | CFO & Treasurer | M | Restricted Stock Unit | 43333 | $0.00 | 86,667.0000 | 47,808,817 | 33.33% | 0.09% |
| Jan. 30, 2025 | Clifton R. LaDuane | CFO & Treasurer | A | Stock Option (right to buy) | 68000 | $0.00 | 68,000.0000 | 47,808,817 | 9999.99% | 0.14% |
| Jan. 30, 2025 | Clifton R. LaDuane | CFO & Treasurer | A | Restricted Stock Unit | 34000 | $0.00 | 34,000.0000 | 47,808,817 | 9999.99% | 0.07% |
| Jan. 31, 2025 | McFarlane Neil F. | President and CEO | M | Common Stock | 233333 | $0.00 | 283,333.0000 | 47,808,817 | 466.67% | 0.49% |
| Jan. 31, 2025 | McFarlane Neil F. | President and CEO | M | Restricted Stock Unit | 233333 | $0.00 | 466,667.0000 | 47,808,817 | 33.33% | 0.49% |
| Jan. 31, 2025 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | M | Common Stock | 11666 | $0.00 | 19,341.0000 | 47,808,817 | 152.00% | 0.02% |
| Oct. 11, 2024 | Watton Corey Michael | Director | P | Common Stock | 500 | $7.92 | 1,500.0000 | 47,808,817 | 50.00% | 0.00% |
| July 17, 2024 | Clifton R. LaDuane | CFO & Treasurer | P | Common Stock | 2000 | $6.77 | 18,469.0000 | 0 | 12.14% | 0.00% |
| July 16, 2024 | Anderson Thomas | Director | P | Common Stock | 10000 | $6.81 | 20,000.0000 | 0 | 100.00% | 0.00% |
| July 12, 2024 | Bode John B | Director | P | Common Stock | 10000 | $5.87 | 30,000.0000 | 0 | 50.00% | 0.00% |
| June 21, 2024 | Thompson Rahsaan | Chief Legal & Compliance | A | Restricted Stock Unit | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | Shih Alvin | Director | A | Stock Option (right to buy) | 39200 | $0.00 | 39,200.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | Bode John B | Director | A | Stock Option (right to buy) | 39200 | $0.00 | 39,200.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | DIXON WENDY L | Director | A | Stock Option (right to buy) | 39200 | $0.00 | 39,200.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | FAVORITO TAMARA A | Director | A | Stock Option (right to buy) | 49200 | $0.00 | 49,200.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | Calder Douglas W | Director | A | Stock Option (right to buy) | 39200 | $0.00 | 39,200.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | Watton Corey Michael | Director | A | Stock Option (right to buy) | 39200 | $0.00 | 39,200.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | Anderson Thomas | Director | A | Stock Option (right to buy) | 39200 | $0.00 | 39,200.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | McFarlane Neil F. | President and CEO | A | Restricted Stock Unit | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Schafer Joshua | CCO & EVP, Bus. Development | A | Restricted Stock Unit | 106000 | $0.00 | 106,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Sangiovanni Timothy J. | SVP, Corporate Controller | A | Restricted Stock Unit | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Mickle Christal M M | Chief Development Officer | A | Restricted Stock Unit | 77000 | $0.00 | 77,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Guenther Sven | Chief Scientific Officer | A | Restricted Stock Unit | 79000 | $0.00 | 79,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Clifton R. LaDuane | CFO, Secretary & Treasurer | A | Restricted Stock Unit | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2024 | Shih Alvin | Director | A | Stock Option (right to buy) | 58800 | $0.00 | 58,800.0000 | 0 | 9999.99% | 0.00% |
| Oct. 10, 2023 | McFarlane Neil F. | President and CEO | A | Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 10, 2023 | McFarlane Neil F. | President and CEO | A | Restricted Stock Unit | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 5, 2023 | Bode John B | Director | P | Common Stock | 10000 | $5.13 | 20,000.0000 | 0 | 100.00% | 0.00% |
| Sept. 6, 2023 | Anderson Thomas | Director | P | Common Stock | 10000 | $4.88 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 6, 2023 | Clifton R. LaDuane | CFO, Secretary & Treasurer | P | Common Stock | 1000 | $4.96 | 15,309.0000 | 0 | 6.99% | 0.00% |
| Sept. 5, 2023 | Schafer Joshua | CCO & EVP, Bus. Development | P | Common Stock | 500 | $5.13 | 3,500.0000 | 0 | 16.67% | 0.00% |
| Aug. 7, 2023 | Anderson Thomas | Director | A | Stock Option (right to buy) | 58800 | $0.00 | 58,800.0000 | 0 | 9999.99% | 0.00% |
| May 19, 2023 | Schafer Joshua | CCO & EVP, Bus. Development | P | Common Stock | 1000 | $5.42 | 3,000.0000 | 0 | 50.00% | 0.00% |
| June 23, 2023 | Watton Corey Michael | Director | P | Common Stock | 275 | $5.95 | 1,000.0000 | 0 | 37.93% | 0.00% |
| June 9, 2023 | Watton Corey Michael | Director | P | Common Stock | 325 | $5.52 | 1,125.0000 | 0 | 40.63% | 0.00% |
| May 31, 2023 | FAVORITO TAMARA A | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2023 | Watton Corey Michael | Director | P | Common Stock | 400 | $5.11 | 400.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Bode John B | Director | P | Common Stock | 100 | $5.05 | 7,549.0000 | 0 | 1.34% | 0.00% |
| May 18, 2023 | Bode John B | Director | P | Common Stock | 1390 | $5.04 | 1,390.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Bode John B | Director | P | Common Stock | 300 | $5.04 | 1,690.0000 | 0 | 21.58% | 0.00% |
| May 18, 2023 | Bode John B | Director | P | Common Stock | 1000 | $5.04 | 2,690.0000 | 0 | 59.17% | 0.00% |
| May 18, 2023 | Bode John B | Director | P | Common Stock | 4759 | $5.04 | 7,449.0000 | 0 | 176.91% | 0.00% |
| May 18, 2023 | Bode John B | Director | P | Common Stock | 2451 | $5.05 | 10,000.0000 | 0 | 32.47% | 0.00% |
| May 18, 2023 | Clifton R. LaDuane | CFO, Secretary & Treasurer | P | Common Stock | 689 | $4.95 | 13,742.0000 | 0 | 5.28% | 0.00% |
| May 18, 2023 | Clifton R. LaDuane | CFO, Secretary & Treasurer | P | Common Stock | 51 | $4.94 | 11,053.0000 | 0 | 0.46% | 0.00% |
| May 18, 2023 | Clifton R. LaDuane | CFO, Secretary & Treasurer | P | Common Stock | 2000 | $4.95 | 13,053.0000 | 0 | 18.09% | 0.00% |
| May 3, 2023 | Calder Douglas W | Director | A | Stock Option (right to buy) | 58800 | $0.00 | 58,800.0000 | 0 | 9999.99% | 0.00% |
| April 25, 2023 | FAVORITO TAMARA A | Director | A | Stock Option (right to buy) | 39200 | $0.00 | 39,200.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2023 | Bode John B | Director | A | Stock Option (right to buy) | 58800 | $0.00 | 58,800.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2023 | DIXON WENDY L | Director | A | Stock Option (right to buy) | 36300 | $0.00 | 36,300.0000 | 0 | 9999.99% | 0.00% |
| April 25, 2023 | DIXON WENDY L | Director | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 0 | 9999.99% | 0.00% |
| April 25, 2023 | Plooster Matthew R | Director | A | Stock Option (right to buy) | 49200 | $0.00 | 49,200.0000 | 0 | 9999.99% | 0.00% |
| April 25, 2023 | Saluri Joseph | Director | A | Stock Option (right to buy) | 39200 | $0.00 | 39,200.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2023 | Watton Corey Michael | Director | A | Stock Option (right to buy) | 58800 | $0.00 | 58,800.0000 | 0 | 9999.99% | 0.00% |
| March 17, 2023 | SEYMOUR TAMARA A | Director | P | Common Stock | 519 | $4.82 | 719.0000 | 0 | 259.50% | 0.00% |
| March 14, 2023 | Schafer Joshua | CCO & EVP, Bus. Development | P | Common Stock | 2000 | $4.61 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| March 10, 2023 | Sangiovanni Timothy J. | SVP, Corporate Controller | P | Common Stock | 1100 | $4.14 | 4,349.0000 | 0 | 33.86% | 0.00% |
| March 10, 2023 | Sangiovanni Timothy J. | SVP, Corporate Controller | P | Common Stock | 100 | $4.14 | 4,449.0000 | 0 | 2.30% | 0.00% |
| March 10, 2023 | Clifton R. LaDuane | CFO, Secretary & Treasurer | P | Common Stock | 1725 | $4.15 | 11,002.0000 | 0 | 18.59% | 0.00% |
| March 9, 2023 | Pascoe Richard W | Chief Executive Officer | P | Common Stock | 10000 | $4.20 | 29,973.0000 | 0 | 50.07% | 0.00% |
| March 9, 2023 | Tierney David S | Director | P | Common Stock | 5000 | $4.15 | 10,835.0000 | 0 | 85.69% | 0.00% |
| March 9, 2023 | Plooster Matthew R | Director | P | Common Stock | 11000 | $4.20 | 20,101.0000 | 0 | 120.87% | 0.00% |
| Jan. 13, 2023 | Clifton R. LaDuane | CFO, Secretary & Treasurer | P | Common Stock | 25 | $5.59 | 9,277.0000 | 0 | 0.27% | 0.00% |
| Jan. 13, 2023 | Clifton R. LaDuane | CFO, Secretary & Treasurer | P | Common Stock | 610 | $5.82 | 9,252.0000 | 0 | 7.06% | 0.00% |
| Jan. 13, 2023 | Pascoe Richard W | Chief Executive Officer | P | Common Stock | 9500 | $5.44 | 19,973.0000 | 0 | 90.71% | 0.00% |
| Jan. 9, 2023 | Guenther Sven | Chief Scientific Officer | A | Stock Option (right to buy) | 306000 | $0.00 | 306,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | Clifton R. LaDuane | CFO, Secretary & Treasurer | A | Stock Option (right to buy) | 459726 | $0.00 | 459,726.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | Mickle Christal M M | Chief Product Dev. Officer | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | Pascoe Richard W | Chief Executive Officer | A | Stock Option (right to buy) | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | Sangiovanni Timothy J. | SVP, Corporate Controller | A | Stock Option (right to buy) | 136986 | $0.00 | 136,986.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | Schafer Joshua | CCO & EVP, Bus. Development | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |